Skip to content
OpenCapital
Get started

Sana Biotechnology SANA Business Sale Proceeds

Business Sale Proceeds at other companies

BioLife Solutions logo
BioLife SolutionsBLFS
$5.88M-68.0%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfProductiveAssets.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's business sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's business sale proceeds?
Sana Biotechnology (SANA) reported business sale proceeds of $248K in Q1 2026.
How has Sana Biotechnology's business sale proceeds changed year-over-year?
Sana Biotechnology's business sale proceeds decreased by 2.0% year-over-year, from $253K to $248K.
What does business sale proceeds mean?
Cash received from divesting business units or subsidiaries, net of cash in the disposed entity.